Ear, Nose and Throat
Conditions
Interventions
Group D
Sponsors
Amir Abouzkry
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age 20 to 60 years old, ASA physical status I & II, Scheduled for nasal surgeries [as septoplasty, rhinoplasty, and FESS (Functional Endoscopic Sinus Surgery)]
Exclusion criteria
Exclusion criteria: Those with bleeding disorders; coagulopathy, on anticoagulant. Also patients with uncompensated cardiac problems (uncontrolled hypertension, ischemic heart disease, or bradyarrhythmia), hepatic patients with uncompensated respiratory, hepatic, or renal impairment, morbidly obese, patients with neurologic disorders (uncooperative or can’t understand the study protocol). Patients who refuse the study plan, patients with history of allergy to medications used in the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome of the study included clarity and dryness of the surgical field estimated every ten minutes by the surgeon. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome of the study included the duration of controlled hypotension, total dose of hypotensive agent used (remifentanil or dexmedetomedine), duration of surgery, duration of anesthesia, time till extubation. Postoperative adverse effects as nausea, vomiting, bradycardia or tachycardia, hypotension or hypertension, agitation and postoperative bleeding will be documented and recorded in PACU. | — |
Countries
Egypt
Contacts
Public ContactAmir Abouzkry
Lecturer of anesthesia and ICU Aswan Universty
Outcome results
None listed